The Latest News from Our Field

We curate a digest of the latest news in our field for advocates, policymakers, community coalitions and all who work toward shaping policies and practices to effectively prevent substance use and treat addiction. Sign up here to receive weekly updates straight to your inbox.

ONDCP released the administration's Drug Policy Priorities for the year.
Thousands of HHS workers were laid off in an agency-wide restructuring, with several key offices eliminated entirely.
States and researchers sue to protect federal health funding, while HHS demands further cuts.
The Supreme Court issued a ruling defending FDA's decision to reject the sale of certain flavored vaping products that appeal to kids.
The Senate confirmed Dr. Mehmet Oz to lead CMS, and HRSA Administrator Tom Engels may lead the new Administration for a Healthy America in HHS.
View our curated digest of the latest research news, including there is a positive association between firearm homicide exposure and marijuana use and also how rising self-pay insurance reliance poses affordability barriers that threaten treatment continuity among patients who rely on buprenorphine prescriptions.
HHS Secretary Kennedy announced a restructuring of the department that would eliminate several agencies and cut 10,000 staff.
HHS is clawing back supplemental COVID relief funding, including $1 billion in block grant funding from SAMHSA.
HHS has cut hundreds of grants, with many related to substance use and mental health, either among gender/sexual minorities or in connection with HIV.
The Trump administration is shifting federal homelessness policy away from Housing First and toward a more punitive response.
Trump announced new nominees for ONDCP director, deputy assistant secretary of SAMHSA, and CDC director, and the NIH, FDA, and CMS nominees advanced.
View our curated digest of the latest research news, including how community-based naloxone distribution programs can be effective in preventing opioid overdose deaths and how positive subjective responses to prescription opioids are predictive of future opioid misuse.
HHS renewed the public health emergency declaration that has been in place for the opioid crisis since 2017.
In a blog, Dr. Volkow outlines why treatments for addiction should be evaluated based on their potential to reduce use, not just abstinence.
Medicaid has been instrumental in paying for opioid overdose response and treatment, so cuts to Medicaid could increase overdoses and deaths.
A new study found that law enforcement drug seizures were associated with increased risk of fatal opioid overdose in the surrounding area in the following days.
View our curated digest of the latest research news, including the high prevalence of mental health issues and interpersonal violence among adolescents with substance use disorders, as well as the increasing presence of xylazine and levamisole as adulterants in illicit drugs.​
The federal agency that leads efforts on mental health and substance use is facing a potential 50-70% workforce reduction.
The nominee for CMS director had a confirmation hearing, the CDC director nominee was withdrawn, and the NIH and FDA nominees progressed.
In an interview with STAT, NIDA Director Volkow discussed the changes at NIH, effective addiction treatment, the recent decline in overdose deaths, and needed research.
Congress passed a continuing resolution to avoid a government shutdown and fund the government through September.
View our curated digest of the latest research news, including how Operant Conditioning appears to be the only treatment component that positively impacts maternal substance use outcomes.
In his address to a joint session of Congress, Trump made little mention of health care or addiction.
Trump implemented, then scaled back, tariffs on Mexico and Canada in response to the ongoing fentanyl crisis.
Trump's nominees to lead NIH and FDA faced questions from senators in their confirmation hearings last week.
1 2 3 50